Annexin A5 may also be used as a biomarker in the study of diseases, such as tumours and asthma, and may promote the occurrence and development of laryngeal cancer and nasopharyngeal carcinoma (Zhang, Meng & Jing, 2022). Here, ANXA5 is linked to asthma.